The following stories appear in full on today's Vidyya Medical News Service Web site.
The Office of Dietary Supplements recently co-sponsored a workshop entitled: Omega-3 Fatty Acids, Diabetes and Cardiovascular Risk. Omega-3 fatty acids had been the subject of debate until the FDA released a statement that supports the claim that the consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. Read recently presented abstracts on the subject of Omega-3 acids in today's issue.
For more information: Abstracts Of Interest: Omega-3 Fatty Acids, Diabetes And Cardiovascular Risk
The Department of Health and Human Services/Food and Drug Administration (HHS/FDA) and the U.S. Department of Agriculture/Food Safety and Inspection Service (USDA/FSIS) on Friday released a draft risk assessment of the potential relative risk of listeriosis from eating certain ready-to-eat foods--as well as an action plan designed to reduce the risk of foodborne illness caused by Listeria monocytogenes.
For more information: HHS And USDA Release Listeria Risk Assessment And Listeria Action Plan
The Food and Drug Administration on Friday published a final regulation requiring all establishments that manufacture human cells, tissues, and cellular and tissue-based products to register and list their products with the agency. When this regulation is fully implemented, it will provide, for the first time, a complete base of information on the tissue bank industry, including certain cells and tissues that were not previously regulated.
For more information: FDA Requires Tissue Banks To Register And List Their Products With The Agency
The Food and Drug Administration on Friday announced a final rule designed to improve the safety of fruit and vegetable juice and juice products. Under the rule, juice processors must use Hazard Analysis and Critical Control Point (HACCP) principles for juice processing. Implementation of a HACCP system will increase the protection of consumers from illness-causing microbes and other hazards in juices.
For more information: FDA Publishes Final Rule To Increase Safety Of Fruit And Vegetable Juices
There is considerable public interest in the United States in claims that extracts of the herb St. John's wort (Hypericum perforatum) may be an effective treatment for depression. In Europe Ė where the herb is now widely prescribed Ė a number of studies have been conducted that support the treatment efficacy of certain St. Johnís wort extracts. However, those studies have had several limitations, creating the need for more definitive research. In response to this need, the National Institute of Mental Health (NIMH) has begun the first large-scale, long-term, controlled clinical trial to assess whether a well standardized St. Johnís wort extract has significant therapeutic benefits for people suffering from major depression.
For more information: Questions And Answers About St. John's Wort
Today's Vidyya articles are:
As always, we hope you enjoy the issue.